ISIS 304801: Clinical Trials

2 trials of ISIS 304801, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow ISIS 304801: new trials by email Literature Review of ISIS 304801 trials Research Report on ISIS 304801

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy
volanesorsen, Placebo - Familial Partial Lipodystrophy
Phase 2 / Phase 3TerminatedAkcea Therapeutics402015-12-282021-10-18
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
ISIS 304801, Placebo - Lipodystrophy
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)52015-12-232020-10-20

Conditions studied

Hypertriglyceridemia (1)  ·  Lipodystrophy (1)  ·  Lipodystrophy, Familial Partial (1)

Sponsors

Akcea Therapeutics (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Russia (1)

Top investigators

Rebecca J Brown, M.D. (1)

Results publications

PMID 36195542, PMID 37164837

NIH funding

2015 (1)